HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 156 | -97.3% | 0.00% | – |
| Q1 2022 | $29,000 | -34.1% | 5,775 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -4.3% | 5,775 | -0.6% | 0.00% | – |
| Q3 2021 | $46,000 | -80.8% | 5,809 | -66.5% | 0.00% | – |
| Q2 2021 | $240,000 | +9.1% | 17,331 | +64.8% | 0.00% | – |
| Q1 2021 | $220,000 | +25.7% | 10,519 | 0.0% | 0.00% | – |
| Q4 2020 | $175,000 | -2.2% | 10,519 | 0.0% | 0.00% | – |
| Q3 2020 | $179,000 | +2.3% | 10,519 | 0.0% | 0.00% | – |
| Q2 2020 | $175,000 | +207.0% | 10,519 | +113.8% | 0.00% | – |
| Q1 2020 | $57,000 | -21.9% | 4,919 | 0.0% | 0.00% | – |
| Q4 2019 | $73,000 | +9.0% | 4,919 | 0.0% | 0.00% | – |
| Q3 2019 | $67,000 | +857.1% | 4,919 | +883.8% | 0.00% | – |
| Q2 2019 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |